KLDO

Kaleido Biosciences Stock Is Trading Higher On Positive KB109 Data In COVID-19 Study

Kaleido Biosciences Reports Positive Results from Non-IND Study Demonstrating a Reduction in COVID-19 Related Healthcare Utilization and Recovery Time in Patients with Mild-to-Moderate COVID-19 and One or More Comorbidity

Kaleido Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results

Kaleido Biosciences to Present at Chardan's 3rd Annual Microbiome Medicines Summit

Kaleido Biosciences (KLDO) Sees Hammer Chart Pattern: Time to Buy?

Kaleido Biosciences Announces the Exercise of the Underwriters' Option to Purchase Additional Shares of Common Stock

Kaleido Biosciences to Present at the Keystone Symposium “Harnessing the Microbiome for Disease Prevention and Therapy” Conference